We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generics manufacturer KVK-Tech was slapped with another warning letter from the FDA over violations at a Newtown, Pennsylvania facility, its second of the year. Read More
A coalition of cystic fibrosis patients, family members and supporters appealed in an open letter to Vertex Pharmaceuticals to expand access to the company’s drugs to treat the disease. Read More
Members of the Sackler family did in fact pressure Purdue Pharma executives to grow its market share of OxyContin and other opioids, according to allegations made in a hefty package of internal documents released by the House Committee on Oversight and Reform. Read More
The U.S. government has struck a $375 million deal with Eli Lilly for 300,000 vials of its investigational COVID-19 treatment, LY-CoV555 (bamlanivimab). Read More
Sanofi and GlaxoSmithKline (GSK) have signed an agreement with Gavi, the Vaccine Alliance pledging to provide 200 million doses of their COVID-19 vaccine to the COVAX initiative should the vaccine clear regulatory hurdles. Read More
No private vendors have stepped up so far to bid on Florida’s $30 million contract to devise a Canadian drug importation program aimed at lowering prescription drug prices in the state. Read More
The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has halted a clinical trial evaluating Eli Lilly’s investigational monoclonal antibody, LY-CoV555 (bamlanivimab), in combination with remdesivir for the treatment of COVID-19 patients. Read More